Compugen (CGEN) Gains from Investment Securities (2017 - 2021)
Compugen recorded quarterly Gains from Investment Securities of $1.1 million in Q4 2021, down 80.99% quarter-over-quarter from $6.0 million in Q4 2020, and down 80.99% year-over-year from $6.0 million in Q4 2020.
Compugen's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $1.1 million for Q4 2021.
- In Q4 2021, Gains from Investment Securities fell 80.99% year-over-year to $1.1 million; the TTM figure through Dec 2021 stood at $1.1 million (down 80.99% YoY), while the FY2025 annual figure was $1000.0, changed N/A from the prior year.
- Gains from Investment Securities came in at $1.1 million for Q4 2021 at Compugen, down from $6.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $8.1 million in Q4 2019 to a low of $1.1 million in Q4 2021.
- A 3-year average of $5.1 million and a median of $6.0 million in 2020 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities declined 26.44% in 2020 and plunged 80.99% in 2021, its largest moves.
- Compugen's Gains from Investment Securities stood at $8.1 million in 2019, then dropped by 26.44% to $6.0 million in 2020, then slumped by 80.99% to $1.1 million in 2021.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $1.1 million, $6.0 million, and $8.1 million for Q4 2021, Q4 2020, and Q4 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.13 Mn |
| Dec 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | 5.96 Mn |
| Dec 31, 2020 | 5.96 Mn |
| Dec 31, 2019 | 8.10 Mn |
| Dec 31, 2019 | 8.10 Mn |
| Dec 31, 2018 | 768,000.00 |
| Dec 31, 2018 | 768,000.00 |
| Dec 31, 2017 | 793,000.00 |
| Dec 31, 2017 | 793,000.00 |